| 产品详情 |
| Edit |   |
|---|
| Product Name | Bischloroanthrabenzoxocinone ((-)BABX) |
|---|
| Description | Purity ≥ 95% by HPLC. Bischloroanthrabenzoxocinone ((-)BABX) is a selective inhibitor of Type II fatty acid synthesis (FASII). BABX showed IC50 values of 11.4 and 35.3ug/ml in the S. aureus and E. coli FASII assays, respectively, with comparable antibacterial activities. Type II fatty acid synthesis (FASII) is essential to bacterial cell viability and is a promising target for the development of novel antibiotics. More recently, BABX has been shown to inhibit agonist binding Liver X receptors (LXR). The receptors regulate the expression of the ABCA1 gene, which mediates the efflux of cholesterol from cells. Source: Bischloroanthrabenzoxocinone Molecular Weight: ~542.1 Solubility: Soluble in ethanol, methanol, DMF or DMSO. Limited water solubility. |
|---|
| Size | 500ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (-)BABX |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | B2176-23 |
|---|
| Price | |
|---|
| Order / More Info | Bischloroanthrabenzoxocinone ((-)BABX) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|